FindTrial
Sign In

Thiamine deficiency among pregnant and lactating women

Gene polymorphism, prevalence, risk factors and dose optimization studies of thiamine in thiamine deficiency states during pregnant and lactating women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044217
Enrollment
500
Registered
2022-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O218- Other vomiting complicating pregnancy

Interventions

Intervention1: Thiamine: Thiamine deficient subjects with the mild deficiency will be randomized into three groups and provided three different doses (i.e. 100 mg OD, 200 mg OD, and 300 mg OD) of thia

Sponsors

Ozaifa Kareem
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant or Lactating

Exclusion criteria

Exclusion criteria: �Patients on multivitamins/thiamine. �Inability to give consent

Design outcomes

Primary

MeasureTime frame
Improvement in thiamine statusTimepoint: At baseline, puerperium, Lactation—

Secondary

MeasureTime frame
Gene polymorphism i.e. frequency of polymorphic SLC19A2 and SLC19A3Timepoint: After the completion of thiamine intervention—

Countries

India

Contacts

Public ContactOzaifa Kareem

Department of Pharmaceutical Sciences, University of Kashmir

gnbader@kashmiruniversity.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026